Until the bill was introduced, Kasimov had been assuming that Keryx Biopharmaceuticals (NASDAQ:KERX) would have to make a roughly 33% gross-to-net discount once it became part of the ESRD bundle ... saw its stock price shoot up …
Keryx Biopharmaceuticals (NASDAQ:KERX - News) stock gained 5.94% to $2.14 +0.12 after the company announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 7th Annual JMP Securities Healthcare …
I haven't exactly been a bull when it comes to Keryx Biopharmaceuticals (NASDAQ: KERX). For starters ... have provided all the warning I need to stay away from the stock. But things may be about to change. No, I'm still not interested in …
John F. Neylan, insider of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) reportedly Sold 1,214 shares of the …
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today the initiation of its short-term Phase 3 study of Zerenex (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or …
NEW YORK, Nov. 17, 2017 /PRNewswire/ -- If you want a Stock Review on DVAX, KERX, MBRX, or TGTX then come …
He tripled his position in KERX through purchases made in late February and early March. The stock was trading below $4 around that time. Currently KERX’s latest price is $4.59. Balyasny gained more than 15% in less than two months from …